Skip to main content
PetMed Express, Inc. (PETS)
NASDAQ: PETS · Real-Time Price · USD
4.080
-0.110 (-2.63%)
At close: Mar 10, 2025, 4:00 PM
4.130
+0.050 (1.23%)
After-hours: Mar 10, 2025, 8:00 PM EST

PetMed Express Revenue

PetMed Express had revenue of $52.98M in the quarter ending December 31, 2024, a decrease of -18.88%. This brings the company's revenue in the last twelve months to $247.01M, down -10.82% year-over-year. In the fiscal year ending March 31, 2024, PetMed Express had annual revenue of $281.06M with 9.54% growth.

Revenue (ttm)
$247.01M
Revenue Growth
-10.82%
P/S Ratio
0.35
Revenue / Employee
$860,662
Employees
287
Market Cap
84.16M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 2024281.06M24.49M9.54%
Mar 31, 2023256.58M-15.70M-5.77%
Mar 31, 2022272.28M-31.30M-10.31%
Mar 31, 2021303.58M19.46M6.85%
Mar 31, 2020284.13M706.00K0.25%
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro
Mar 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 400.28B
Johnson & Johnson 88.82B
Merck & Co. 64.17B
AbbVie 56.33B
AstraZeneca 54.07B
Novartis AG 51.72B
Eli Lilly and Company 45.04B
Thermo Fisher Scientific 42.88B
Revenue Rankings

PETS News

More News